Jacqueline Nathansen
Overview
Explore the profile of Jacqueline Nathansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nathansen J, Meyer F, Muller L, Schmitz M, Borgmann K, Dubrovska A
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638302
Cancer stem cells (CSCs) are pluripotent and highly tumorigenic cells that can re-populate a tumor and cause relapses even after initially successful therapy. As with tissue stem cells, CSCs possess...
2.
Nathansen J, Lukiyanchuk V, Hein L, Stolte M, Borgmann K, Lock S, et al.
Oncogene
. 2021 Jun;
40(24):4214-4228.
PMID: 34079088
Head and neck squamous cell carcinoma (HNSCC) is often being diagnosed at an advanced stage, conferring a poor prognosis. The probability of local tumor control after radiotherapy depends on the...
3.
Watermann C, Pasternack H, Idel C, Ribbat-Idel J, Bragelmann J, Kuppler P, et al.
Clin Cancer Res
. 2020 Oct;
27(2):632-644.
PMID: 33109740
Purpose: Recurrent tumors (RT) of head and neck squamous cell carcinoma (HNSCC) occur in up to 60%, with poor therapeutic response and detrimental prognosis. We hypothesized that HNSCC RTs successfully...
4.
Peitzsch C, Nathansen J, Schniewind S, Schwarz F, Dubrovska A
Cancers (Basel)
. 2019 May;
11(5).
PMID: 31052565
Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed cancer worldwide. Despite advances in the treatment management, locally advanced disease has a poor prognosis, with a...